30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Smith & Nephew launched the Syncera sales model in the U.S. to offer hospitals the SYNERGY stem + REFLECTION cup and the GENESIS II knee, clinically-proven primary joint replacement products that should address >80% of procedures and represent at least 5% to 10% of U.S. market. The initiative includes technology to streamline the supply chain and logistics, ensure automatic replenishment of products, etc., and includes technical support and training in lieu of a rep in the OR. Healthcare providers will enter into a multi-year contract to purchase the instrument set and own the implant inventory, allowing implants to be offered at a substantial discount to U.S. average price. (Smith & Nephew, 8/1/14)